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Abstract
Cyclic AMP (cAMP) is a signaling molecule that is involved in the regulation
of multiple virulence systems of the opportunistic pathogen Pseudomonas
aeruginosa. The intracellular concentration of cAMP in P. aeruginosa cells is
tightly controlled at the levels of cAMP synthesis and degradation through
regulation of the activity and/or expression of the adenylate cyclases CyaA and
CyaB or the cAMP phosphodiesterase CpdA. Interestingly, mutants of fimL,
which usually demonstrate defective twitching motility, frequently revert to a
wild-type twitching-motility phenotype presumably via the acquisition of an
extragenic suppressor mutation(s). In this study, we have characterized five
independent fimL twitching-motility revertants and have determined that all
have increased intracellular cAMP levels compared with the parent fimL
mutant. Whole-genome sequencing revealed that only one of these fimL rever-
tants has acquired a loss-of-function mutation in cpdA that accounts for the
elevated levels of intracellular cAMP. As mutation of cpdA did not account for
the restoration of twitching motility observed in the other four fimL revertants,
these observations suggest that there is at least another, as yet unidentified, site
of extragenic suppressor mutation that can cause phenotypic reversion in fimL
mutants and modulation of intracellular cAMP levels of P. aeruginosa.
Introduction
Pseudomonas aeruginosa is a Gram negative opportunistic
pathogen, which grows in soil, marine environments, and
infects many organisms including plants, nematodes,
insects, and animals (Mahajan-Miklos et al. 2000; Rahme
et al. 2000). In humans, P. aeruginosa causes serious, and
often chronic, infections in those with cystic fibrosis and
in immunocompromised individuals, such as those with
AIDS, patients undergoing chemotherapy and those with
severe burns (Lyczak et al. 2000; Tatterson et al. 2001).
The success of this organism in various environments is
attributed to its broad metabolic versatility (Stover et al.
2000) and its ability to produce many cell-associated and
secreted virulence and survival factors (Van Delden and
Iglewski 1998).
In P. aeruginosa, the expression of these factors is
regulated by components of a large number of complex
signaling pathways. One signaling molecule associated
with regulation of virulence factors is 3′,5′-cyclic adeno-
sine monophosphate (cAMP). In P. aeruginosa, cAMP is
an allosteric regulator of the transcriptional activator Vfr
(virulence factor regulator) (West et al. 1994), which has
been shown to regulate, either directly or indirectly, more
than 200 genes, including those associated with biogenesis
and function of type IV pili (tfp), type III secretion sys-
tems (T3SS), flagella-mediated motility, and quorum
sensing systems (Albus et al. 1997; Beatson et al. 2002;
Dasgupta et al. 2002; Wolfgang et al. 2003).
As cAMP is involved in controlling such a wide range
of important cellular functions, it is imperative that
cAMP homeostasis is tightly controlled. In P. aeruginosa,
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cAMP is synthesized by two adenylate cyclases, CyaA and
CyaB, with the latter contributing the majority of intra-
cellular cAMP (icAMP) (Wolfgang et al. 2003; Fulcher
et al. 2010). In P. aeruginosa, the 3′-5′ nucleotide phos-
phodiesterase CpdA serves to reduce the levels of intra-
cellular cAMP by hydrolyzing the phosphodiester bond to
release the biologically inactive 5′-AMP (Fuchs et al.
2010). Expression of cpdA is positively regulated by Vfr in
response to elevated levels of icAMP (Fuchs et al. 2010).
The P. aeruginosa Chp chemosensory system and FimL
have been shown to be involved in the modulation of
icAMP levels (Fulcher et al. 2010; Inclan et al. 2011). The
Chp chemosensory system shares many components in
common with chemosensory systems that regulate flagella
rotation in bacteria and in P. aeruginosa is thought to
regulate the motors that control the extension and retrac-
tion of tfp to mediate a form of surface translocation
termed twitching motility (Darzins 1993, 1994, 1995;
Whitchurch et al. 2004). Control of icAMP levels by the
Chp system appears to be mediated by the CheY-like
components of the Chp system, PilG and PilH, which are
thought to modulate icAMP levels by modulating CyaB
activity (Fulcher et al. 2010).
The P. aeruginosa protein FimL is homologous to the
N-terminal domain of ChpA and is required for normal
twitching motility in P. aeruginosa strains PAO1 and
PA103 (Whitchurch et al. 2005). Mutants of fimL have
been recently shown to have reduced levels of icAMP
compared with isogenic wild-type strains (Fulcher et al.
2010; Inclan et al. 2011). It has been suggested that
regulation of icAMP levels by FimL may occur through
posttranslational modulation of CyaB activity (Inclan
et al. 2011).
We have previously reported that revertants of fimL
mutants frequently arise that have regained near-wild-type
twitching motility, presumably due to the acquisition of
an extragenic suppressor mutation(s) (Whitchurch et al.
2005). Twitching-motility revertants were readily detect-
able as flares of twitching cells erupting from the edges
of surface or interstitial colonies of fimL mutants
(Whitchurch et al. 2005). One PAO1DfimL revertant was
examined in more detail and was found to have signifi-
cantly increased icAMP levels compared with the parent
fimL mutant (Whitchurch et al. 2005).
In this study, we have characterized another five inde-
pendently isolated fimL twitching-motility revertants and
have determined that all had increased icAMP levels com-
pared with the parent fimL mutant. Whole-genome
sequencing of one of these strains revealed that it had
acquired a loss-of-function mutation in cpdA that
accounts for the elevated icAMP levels and restoration of
twitching motility. Characterization of the other four fimL
revertants indicates that there is at least one other site of
suppressor mutation that can cause phenotypic reversion
in fimL mutants and that is involved in modulation of
icAMP levels of P. aeruginosa.
Methods
Bacterial strains, plasmids, and media
The strains used in this study and their relevant charac-
teristics are shown in Table 1. Escherichia coli strain
DH5a was used in all genetic manipulations and in the
preparation of DNA sequencing templates, and E. coli
S17-1 was used as the donor strain in bacterial conjuga-
tion for allelic exchange mutagenesis.
Pseudomonas aeruginosa and E. coli were cultured on
Luria–Bertani (LB) (Sambrook et al. 1989) broth solidi-
fied with agar at 1.5% or 1% (for twitching-motility stab
assays) and grown overnight at 37°C. Cultures were
grown in either cation-adjusted Mueller Hinton broth
(CAMHB) or LB broth for P. aeruginosa, or LB broth for
E. coli, and incubated overnight at 37°C, with shaking at
250 rpm. Light microscopy was performed with nutrient
media (4 g/L tryptone, 2 g/L, yeast extract, 2 g/L NaCl)
solidified with 8 g/L GelGro (ICN). Antibiotic concentra-
tions used for selection of E. coli were 100 lg/mL ampi-
cillin, 12.5 lg/mL tetracycline, and 50 lg/mL kanamycin,
and for P. aeruginosa were 250 lg/mL carbenicillin and
200 lg/mL tetracycline.
Recombinant DNA techniques
The preparation of plasmid DNA (Qiagen, Valencia, CA),
restriction endonuclease digestion (New England Biolabs,
Ipswich, MA), and ligation reactions (Promega, Madison,
WI, and New England Biolabs) were carried out using
standard protocols (Sambrook et al. 1989). The prepara-
tion of E. coli competent cells and transformations were
performed as previously described (Sambrook et al.
1989). Pseudomonas aeruginosa competent cells were pre-
pared by MgCl2 treatment and transformed as previously
described (Mattick et al. 1987). Pseudomonas aeruginosa
cells were prepared by sucrose treatment for electro-
poration and electroporated as previously described (Choi
et al. 2006) with the following modifications: briefly,
overnight 10 mL CAMHB cultures of P. aeruginosa were
harvested by centrifugation at 3000g for 10 min at 4°C.
The cell pellet was washed four times in 1 mL of ice-cold
300 mmol/L sucrose, and finally resuspended in 200 lL
of ice-cold 300 mmol/L sucrose. Three hundred nano-
grams of plasmid DNA was added to 80–100 lL of elec-
trocompetent cells, incubated at room temperature for
5 min, and then transferred to a 1-mm gap-width electro-
poration cuvette. After applying a pulse (settings: 25 lF;
ª 2012 The Authors. MicrobiologyOpen published by Blackwell Publishing Ltd. 491
L. M. Nolan et al. fimL Revertants Have Elevated cAMP
200 Ω; 2.5 kV on a BTX 600 Electro Cell Manipulator;
Harvard Apparatus Inc., Holliston, MA), the cells were
added to 1 mL of CAMHB with 0.2% glucose and incu-
bated at 37°C, shaking, for 1 h and then plated onto LB
agar containing appropriate antibiotic selection.
Particular care was taken to ensure that fimL revertants
were not inadvertently included in PAO1fimL::Tn5-Tc
transformations. Vector controls and CpdA alleles were
transformed using the same preparation of competent
cells, and at least 10 independent colonies of PAO1fimL::
Tn5-Tc transformants were chosen for further phenotypic
characterizations including confirmation that the vector-
control transformants had the expected abrogated twitching-
motility phenotype.
Phenotypic assays
Twitching motility was assayed using a modification of
the subsurface stab assay described previously (Semmler
et al. 1999). Briefly, the P. aeruginosa strain to be tested
was stab inoculated through a 1% agar plate and after
overnight growth at 37°C, the zone of interstitial biofilm
expansion at the agar and petri dish interface was
visualized by flooding the plate with a solution of 20%
methanol and 10% acetic acid. The longest (a) and short-
est (b) diameters of each interstitial biofilm were mea-
sured and the surface area calculated using the formula:
area = abp.
Microscopic analysis of twitching motility-mediated
interstitial biofilm expansion on GelGro-solidified nutri-
ent media was assayed using a modification of the slide
assay described previously (Semmler et al. 1999). Briefly,
5 mL of molten Gelgro nutrient media was poured across
four slides on a level surface and allowed to set. The slide
was dried briefly and spotted with a small inoculum of
the strain of interest taken from a fresh overnight plate
culture. A 22 9 40-mm coverslip (0.13- to 0.16-mm
thick) was carefully placed onto the solidified media and
incubated at 37°C for 5 h. The GelGro slide was moved
to the stage of an Olympus IX71 inverted research micro-
scope fitted with phase contrast objectives. Images acqui-
sition was performed using a FViewII camera (Olympus
Corporation, Toyko, Japan) driven by AnalySIS Research
Pro software (Soft Imaging Systems, Olympus).
Intracellular cAMP (icAMP) assays were performed as
described previously (Fulcher et al. 2010). Briefly, strains
were subcultured 1/100 from an overnight CAMHB cul-
ture into LB and incubated at 37°C with shaking until
OD600 = 1.0. 1.5 mL of cells were harvested by centrifu-
gation at 13,000g for 2 min at 4°C and washed twice with
Table 1. Strains and plasmids used in this study.
Strains Relevant characteristic(s) Source or reference
Escherichia coli
DH5a recA endA1 gyrA96 hsdR17 thi-1 supE44 relA1 φ80 dlacZDM15 Invitrogen
S17-1 thi pro hsdR recA chr::RP4-2 Simon et al. (1983)
Pseudomonas aeruginosa
PAO1 Wild-type P. aeruginosa strain ATCC 15692 American Type Culture
Collection
PAO1pilA PAO1 with pilA inactivated by allelic displacement with a tellurite resistance cassette;
TelR
Klausen et al. (2003)
PAO1293-31E6 PAO1293 with mTn5-Tc insertion in fimL; TcR Whitchurch et al. (2005)
PAO1fimL::mTn5-Tc PAO1 with same mTn5-Tc insertion in fimL as PAO1293-31E6; TcR This study
PAO1fimLRev1 Independent twitching-motility revertant isolated from PAO1fimL:: mTn5-Tc; Tc
R This study
PAO1fimLRev2 Independent twitching-motility revertant isolated from PAO1fimL:: mTn5-Tc; Tc
R This study
PAO1fimLRev3 Independent twitching-motility revertant isolated from PAO1fimL:: mTn5-Tc; Tc
R This study
PAO1fimLRev4 Independent twitching-motility revertant isolated from PAO1fimL:: mTn5-Tc; Tc
R This study
PAO1fimLRev5 Independent twitching-motility revertant isolated from PAO1fimL:: mTn5-Tc; Tc
R This study
Plasmids
pUCPSK P. aeruginosa-E. coli shuttle vector; ApR Watson et al. (1996)
pGEM-T E. coli cloning vector; ApR Promega
pOK12 E. coli cloning vector; KmR Vieira and Messing (1991)
pRIC380 P. aeruginosa suicide vector; ApR Alm and Mattick (1996)
pSB62.4 Marker rescue clone of PAO1293-31E6 genomic DNA containing fimL::mTn5-Tc
insertion site; ApR, TcR
Whitchurch et al. (2005)
pSB172.10 3.1-kb PstI insert from pSB62.4 cloned into pOK12; KmR, TcR This study
pSB172.1 3.1-kb SpeI insert from pSB172.10 cloned into pRIC380; ApR, TcR This study
pUCPCpdA cpdA amplified from wild-type PAO1 and cloned into pUCPSK with Plac; ApR This study
pUCPCpdAL187R cpdA amplified from PAO1fimLRev1 and cloned into pUCPSK with Plac; Ap
R This study
pUCPCpdAR75G cpdA amplified from PAO1fimLRev2 and cloned into pUCPSK with Plac; Ap
R This study
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ice-cold 0.9 mol/L NaCl. Pellets were resuspended in
100 lL 0.1 N HCl and incubated on ice for 10 min with
occasional vortexing to lyse the bacteria. Lysates were cen-
trifuged at 13,000g for 5 min at 4°C to remove cellular
debris, and the supernatant used to measure intracellular
cAMP with an enzyme-linked immunosorbent assay
(ELISA)-based assay (Cayman Chemical Company, Ann
Arbor, MI) as per manufacturer’s instructions.
Construction of isogenic fimL mutant and
isolation of revertant strains
A fimL allelic exchange mutant in PAO1 was constructed
by using the sucrose counterselection system described
previously (Schweizer 1992; Alm and Mattick 1996). A
3.1-kb PstI fragment containing the fimL::mTn5-Tc allele
from PAO2913-31E6 was subcloned from the marker res-
cue clone pSB62.4 into the vector pOK12. The resultant
clone pSB172.10 was then digested with SpeI and the
fimL::mTn5-Tc allele cloned into the suicide vector
pRIC380 to produce pSB172.1. This vector carries the
genes sacBR, which promotes sensitivity to sucrose, and
oriT, which enables conjugal transfer. pSB172.1 was trans-
formed into the E. coli donor strain S17-1 in preparation
for mating with P. aeruginosa PAO1. Following conjuga-
tion, the transconjugants were plated onto 5% sucrose
medium containing tetracycline to select for colonies in
which the plasmid had excised while leaving the homo-
logously recombined fimL::mTn5-Tc allele in the chromo-
some. Mutants were genotypically confirmed by Southern
blot analysis.
Sequencing and sequence analysis
PAO1fimLRev1 genomic DNA was sequenced using an
Applied Biosystems SOLiD System 2.0 sequencer at the
High-throughput DNA Sequencing Unit, University of
Otago, New Zealand. The 2 9 25-bp mate-pair format
was utilized for sequencing with insert sizes between 1.5
and 2.5 kb. Approximately 34 million individual
sequence tags were mapped, with an average depth of
131-fold coverage, to the reference genome of
P. aeruginosa PAO1 (NC_002516.2) using the SOLiD Sys-
tem Analysis Pipeline Tool (corona lite). Fourteen high-
quality SNPs were identified in PAO1fimLRev1 relative to
the P. aeruginosa PAO1 reference genome including three
that were located in intergenic regions. In total, nonsyn-
onymous substitutions were detected in seven protein-
coding genes: PA0159, W35C (183697T>C); PA0400,
A125R (4423850C>G); PA1029, M1V (1116213G>C);
PA1459, G34A (1589438G>C); PA2400/PvdJ, P819A
(2669175G>C); PA4341, E158D (4869855T>G); and
PA4969/CpdA, L187R (5578940A>C).
The nucleotide sequences of the coding and upstream pro-
moter regions of cpdA, cyaA, cyaB, pilG, pilH, and vfr were
obtained by PCR amplification of the region of interest from
the P. aeruginosa PAO1 genome and cloning of the amplicon
into pGEM-T (or pUCPSK in the case of vfr). Automated
DNA sequencing of the pGEM-T clones was performed by the
Australian Genome Research Facility (University of Queens-
land, Brisbane, Queensland, Australia) and Macrogen Inc.
(Seoul, Korea) using BigDye terminator chemistries. cpdA was
amplified using the forward primer 5′-CATCGGGAACGG-
GCTAATG-3′ and the reverse primer 5′-GTAGACCCGCAC-
TTCCAGCC-3′; cyaA was amplified using the forward primer
5′-CTGAGCGGACGGAAAGTC-3′, and the reverse primer
5′-CAGCGAGCAGGGTAATAC-3′; cyaB was amplified using
the forward primer 5′-GCATCGGTCTCTTCTTGTTC-3′ and
the reverse primer 5′-GTTTCGGCGGAGGAGTTC-3′; pilG
and pilH were amplified using the forward primer 5′-TCC-
GGGCATTATGGATAGAG-3′ and the reverse primer 5′-AA-
CCGCAGAGGTCCATGAT-3′; vfr was amplified using the
forward primer 5′-GCCGGTACCCTTGACCACGAAGTGC-3′
(KpnI site underlined) and the reverse primer 5′-CCTAA-
GCTTGTTCTTCCAGGAGCGTGG-3′ (HindIII site under-
lined). Nucleotide and predicted protein sequences were
analyzed using MacVector (Oxford Molecular Group,
Oxford, UK).
Protein homology modeling
Primary amino acid alignments were carried out using
ClustalW software (Thompson et al. 1994). A homology
model of wild-type CpdA from P. aeruginosa was gener-
ated using the comparative alignment of Rv0805 from
Mycobacterium tuberculosis and CpdA and the high-
resolution (1.8 A) structure of Rv0805 (PDB: 3IB8) from
M. tuberculosis as the template to build the CpdA three-
dimensional structure with Modeller (Sali and Blundell
1993; available at: http://www.salilab.org/modeller/).
Results
fimL revertants have increased intracellular
cAMP levels
In order to further investigate the mechanism(s) of
phenotypic reversion of fimL mutants, we isolated
five independent twitching-motility revertants of the
PAO1 fimL mutant PAO1fimL::mTn5-Tc. These fimL
revertant strains are herein designated PAO1fimLRev1,
PAO1fimLRev2, PAO1fimLRev3, PAO1fimLRev4, and PAO1-
fimLRev5.
The twitching-motility phenotypes of the five revertants
were examined via the subsurface stab assay in which
wild-type twitching motility results in rapid expansion of
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the interstitial biofilm that forms at the agar–petri dish
interface. In this assay nontwitching mutants (such as pilA
mutants) show no zone of biofilm expansion (Fig. 1A and
B). As expected, the fimL mutant PAO1fimL::mTn5-Tc
displayed severely abrogated twitching motility producing
only a small zone of interstitial biofilm expansion via this
assay (Fig. 1A and B) as described previously for a fimL
deletion mutant of PAO1 (Whitchurch et al. 2005). Each
of the fimL revertants demonstrated significantly greater
twitching motility than the parental PAO1fimL::mTn5-Tc,
although none had attained complete restoration to wild-
type PAO1 levels (Fig. 1A and B).
Light microscopy was used to examine the twitching
motility-mediated biofilm expansion that occurs at the
interstitial interface of a glass coverslip and a pad of
nutrient media solidified with gellan gum. Under these
conditions, wild-type P. aeruginosa interstitial biofilms
actively expand via tfp-mediated twitching motility and
produce a characteristic micromorphological pattern that
is comprised of rafts of cells at the leading edge of the
biofilm, behind which forms an intricate lattice-like
network of cells (Fig. 1C; Semmler et al. 1999). Non-
twitching mutants, such as pilA mutants, demonstrate no
differentiation of the biofilm edge (Fig. 1C; Semmler
et al. 1999) and fimL mutants form large rafts of cells at
the leading edge, but do not produce the intricate lattice-
like network (Fig. 1C; Whitchurch et al. 2005). Micro-
scopic examination of interstitial biofilms produced by
the PAO1fimL::mTn5-Tc fimL revertant strains revealed
obvious differences in the micromorphological patterns of
the interstitial biofilms. The interstitial biofilms formed
by PAO1fimLRev5 were most similar to those formed by
wild-type PAO1, except that the leading-edge rafts were
routinely smaller than wild-type (Fig. 1C). The micro-
morphological patterns of the interstitial biofilms formed
by PAO1fimLRev2 routinely displayed wide leading-edge
rafts and thicker trails immediately behind the rafts
(Fig. 1C). Interestingly, the interstitial biofilms of PAO1-
fimLRev1 and PAO1fimLRev3 had similar leading-edge rafts
to wild-type, but lacked the ability to form the intricate
(A) (B)
(C) (D)
Figure 1. Phenotypic reversion of fimL mutants. (A and B) Subsurface twitching motility-mediated interstitial biofilm expansion at agar/plastic
interface after 24-h incubation at 37°C. (A) Scanned images of interstitial biofilms of PAO1, PAO1pilA, PAO1fimL::mTn5-Tc, PAO1fimLRev1,
PAO1fimLRev2, PAO1fimLRev3, PAO1fimLRev4, and PAO1fimLRev5. Bar represents 1 cm. (B) Areas of interstitial biofilms were measured and
presented as the mean  SD from three independent experiments performed in triplicate (***P < 0.0001, Mann–Whitney U test compared with
PAO1fimL::mTn5-Tc). (C) Light microscopy images of typical biofilm expansion at the interstitial surface between glass coverslip and Gelgro-
solidified nutrient media by PAO1, PAO1pilA, PAO1fimL::mTn5-Tc, PAO1fimLRev1, PAO1fimLRev2, PAO1fimLRev3, PAO1fimLRev4, and PAO1fimLRev5.
Strains were incubated at 37°C for 5 h before imaging. Bar represents 100 lm. (D) Intracellular cAMP concentrations of PAO1, PAO1fimL::mTn5-
Tc, PAO1fimLRev1, PAO1fimLRev2, PAO1fimLRev3, PAO1fimLRev4, and PAO1fimLRev5. Data are presented as the mean  SD for four independent
experiments performed in triplicate (***P < 0.0001; **P < 0.005 Mann–Whitney U test compared with PAO1fimL:: mTn5-Tc).
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lattice-like network of trails (Fig. 1C). Instead, the cells
were loosely distributed in the region behind the leading-
edge rafts (Fig. 1C). Finally, the interstitial biofilms
formed by PAO1fimLRev4 appeared very similar to the
parental PAO1fimL::mTn5-Tc and were comprised of
extremely large, wide rafts and the cells in the regions
behind the rafts were densely packed and lacked any kind
of lattice-like network arrangement (Fig. 1C).
We have previously determined that a revertant of
PAO1DfimL showed increased levels of icAMP
(Whitchurch et al. 2005). To determine whether elevated
icAMP is a phenotype common to all fimL revertants,
we assayed icAMP levels for each of the five fimL rever-
tants obtained in this study as well as the parent PAO1-
fimL::mTn5-Tc and wild-type PAO1 strains (Fig. 1D).
We found that under the conditions of our assay, PAO1-
fimL::mTn5-Tc has reduced icAMP levels relative to
wild-type PAO1 (Fig. 1D), as has been described previ-
ously (Inclan et al. 2011). Interestingly, each of the five
fimL revertants showed significantly elevated levels of
icAMP relative to their parent PAO1fimL::mTn5-Tc
strain, although the levels of intracellular cAMP varied
widely (Fig. 1D). Strains PAO1fimLRev1, PAO1fimLRev3,
and PAO1fimLRev5 had icAMP levels that were 10- to
20-fold higher than wild-type PAO1, whereas PAO1
fimLRev2 had icAMP levels that were only twofold higher
than PAO1, and PAO1fimLRev4 had wild-type icAMP lev-
els (Fig. 1D). These observations suggest that extragenic
suppressor mutations that lead to elevated icAMP levels
are able to restore, at least in part, twitching motility to
the PAO1fimL::mTn5-Tc mutant.
cpdA is one site of extragenic suppressor
mutation of fimL
To identify the site of the extragenic suppressor mutation
in fimL revertants, we first sequenced the genome of
PAO1fimLRev1 and compared this with the available gen-
ome sequence of PAO1 (Stover et al. 2000; Winsor et al.
2011). Seven single nucleotide polymorphisms (SNPs)
causing nonsynonymous amino acid substitutions were
identified in the genome sequence of PAO1fimLRev1. One
of these SNPs was located in cpdA, which encodes a cAMP
phosphodiesterase responsible for cAMP degradation in
P. aeruginosa (Fuchs et al. 2010). Given the observed ele-
vated icAMP levels in all of our fimL revertants, we consid-
ered the possibility that cpdA may be the site of extragenic
suppressor mutation in PAO1fimLRev1 that is responsible
for the observed phenotypic reversion of twitching motility
and icAMP levels. This is also consistent with the observa-
tions of Inclan et al. (2011), who found that deletion of
cpdA restores twitching motility and T3SS function to a
PAO1 fimL mutant (Inclan et al. 2011).
The SNP in cpdA of PAO1fimLRev1 was confirmed by
PCR amplification of cpdA from PAO1fimLRev1 and
sequence analysis of the cloned amplicon. The SNP in
cpdA results in a leucine-to-arginine amino acid substitu-
tion at position 187 (L187R). To determine whether this
SNP in cpdA is responsible for the observed increased
icAMP levels and restoration of twitching motility in
PAO1fimLRev1, the plasmid pUCPCpdA (containing wild-
type cpdA) was transformed into PAO1, PAO1fimL::
mTn5-Tc, and PAO1fimLRev1. Consistent with cpdA
encoding a cAMP phosphodiesterase, introduction of
pUCPCpdA significantly reduced icAMP levels in both
wild-type PAO1 and PAO1fimLRev1 (Fig. 2B). Interest-
ingly, the presence of pUCPCpdA reduced twitching
motility of PAO1fimLRev1 to levels similar to those of the
parental PAO1fimL::TcR, whereas the reduction in twitch-
ing motility was not as severe when pUCPCpdA was
present in PAO1 (Fig. 2A). As introduction of the wild-
type CpdA allele to PAO1fimLRev1 restored the severely
abrogated twitching-motility phenotype and icAMP to
parental PAO1fimL::mTn5-Tc levels, this indicates that
the L187R SNP in cpdA is likely to be the site of suppres-
sor mutation in PAO1fimLRev1.
After determining that the mechanism of reversion in
PAO1fimLRev1 is likely to be via acquisition of an extra-
genic suppressor mutation in cpdA that results in elevated
icAMP levels and restoration of twitching motility, we
wanted to determine if cpdA is also the site of suppressor
mutation in the other fimL revertants (PAO1fimLRev2,
PAO1fimLRev3, PAO1fimLRev4, and PAO1fimLRev5). Inter-
estingly, introduction of pUCPCpdA did not restore the
abrogated twitching motility to any of these revertants,
nor did it reduce the levels of icAMP to the same extent
as when it was introduced into PAO1 or PAO1fimLRev1.
These observations suggest that cpdA may not be the site
of suppressor mutation in these revertants and further-
more, suggest that the suppressor mutation in these
strains is causing elevation of icAMP levels by a mecha-
nism(s) that is less affected by the activity of exogenous
CpdA expressed from pUCPCpdA.
We also sequenced the coding and upstream promoter
regions of cpdA from these four fimL revertant strains.
Sequence analysis revealed that three of the fimL rever-
tants (PAO1fimLRev3, PAO1fimLRev4, and PAO1fimLRev5)
have wild-type cpdA sequences confirming that the site of
extragenic suppressor mutation has occurred elsewhere in
these strains. Interestingly, PAO1fimLRev2 was found to
have acquired a SNP in cpdA, which is predicted to result
in an arginine-to-glycine amino acid change at position 75
(CpdAR75G). However, the observation that introduction
of wild-type cpdA did not complement the revertant
twitching motility and icAMP phenotypes back to paren-
tal fimL mutant levels suggests that this may not be the
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primary site of suppressor mutation in this strain or that
the CpdAR75G allele is dominant negative over the intro-
duced wild-type CpdA allele.
CpdA alleles from fimL revertants have
reduced activities in vivo
Our results suggest that fimL mutants are able to restore
twitching motility by acquiring extragenic suppressor
mutations that lead to elevated icAMP levels, and that
this increase is generated via at least two different mecha-
nisms. In PAO1fimLRev1 and PAO1fimLRev2, we have iden-
tified two different SNPs in cpdA, which appear to affect
CpdA activity, at least one of which (L187R) is likely to
be responsible for phenotypic reversion in PAO1fimLRev1.
To further investigate the effect of these SNPs on CpdA
activity, we cloned each of the cpdA genes from PAO1-
fimLRev1 (pUCPCpdAL187R) and PAO1fimLRev2 (pUC-
PCpdAR75G), and assayed the in vivo activity of each
allele by measuring twitching motility and icAMP levels
in PAO1-harboring clones expressing wild-type and
mutant CpdA alleles (Fig. 3). These assays show that
while pUCPCpdA significantly reduced both twitching
(A)
(B)
Figure 2. CpdA restores fimL phenotypes to PAO1fimLRev1.
(A) Subsurface twitching motility-mediated interstitial biofilm expansion
at the agar/plastic interface. Areas of interstitial biofilms of PAO1,
PAO1fimL::mTn5-Tc, PAO1fimLRev1, PAO1fimLRev2, PAO1fimLRev3,
PAO1fimLRev4, and PAO1fimLRev5 transformed with pUCPSK (solid
bars) and pUCPCpdA (open bars) were measured after 24-h
incubation at 37°C. Data are presented as the mean  SD for three
independent experiments performed in triplicate. (B) Intracellular
cAMP concentrations of PAO1, PAO1fimL::mTn5-Tc, PAO1fimLRev1,
PAO1fimLRev2, PAO1fimLRev3, PAO1fimLRev4, and PAO1fimLRev5
transformed with pUCPSK (solid bars) and pUCPCpdA (open bars).
Data are presented as the mean  SD for four independent
experiments performed in triplicate.
(A)
(B)
Figure 3. In vivo activities of CpdA alleles. (A) Subsurface twitching
motility-mediated interstitial biofilm expansion at the agar/plastic
interface. Areas of interstitial biofilms of PAO1 transformed with
pUCPSK, pUCPCpdA, pUCPCpdAL187R, and pUCPCpdAR75G were
measured after incubation at 37°C for 24 h. The data are presented
as the mean  SD from three independent experiments performed in
triplicate (***P < 0.0001, Mann–Whitney U test compared with PAO1
transformed with pUCPSK). (B) Intracellular cAMP concentrations of
PAO1 transformed with pUCPSK pUCPCpdA, pUCPCpdAL187R, and
pUCPCpdAR75G. Data are presented as the mean  SD for four
independent experiments performed in triplicate (***P < 0.0001,
Mann–Whitney U test compared with PAO1 transformed with
pUCPSK).
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motility and icAMP levels, pUCPCpdAL187R did not
influence either twitching motility or icAMP levels sug-
gesting that the L187R mutation leads to a loss-of-enzyme
function in vivo. PAO1 containing pUPCpdAR75G dem-
onstrated a mild reduction in both twitching motility and
icAMP levels, which suggests that the R75G mutation
leads to an enzyme with attenuated, but not absent, phos-
phodiesterase activity. Furthermore, as introduction of
the CpdAR75G allele did not result in elevation of icAMP
levels, these observations indicate that the CpdAR75G
allele is not dominant negative over the wild-type CpdA
allele present in PAO1.
To further investigate how the L187R and R75G
substitutions are likely to affect CpdA activity, we first
generated a homology model of P. aeruginosa CpdA.
Information on the structure and catalytic mechanism of
Escherichia coli CpdA has been previously deduced by
generating a homology model based on the pig purple
acid phosphatase structural template (Richter 2002). We
decided that a similar analysis might yield insights into
the effects of the amino acid substitutions on the activity
of the CpdA alleles from PAO1fimLRev1 and PAO1fimLRev2.
The primary sequences of CpdA homologs from E. coli,
Enterobacter aerogenes, and Mycobacterium tuberculosis
were aligned with CpdA from P. aeruginosa using
ClustalW (Thompson et al. 1994), then adjusted manually
to allow for minor poor matches caused by the E. aeroge-
nes GpdQ sequence (Fig. 4A). Marked on the alignment
are the five highly conserved and histidine-rich metal ion-
binding sites and the leucine187 or arginine75 that are
(A) (B)
(C) (D)
Figure 4. Homology modeling of CpdA alleles. (A) ClustalW alignment of Pseudomonas aeruginosa CpdA and homologues. ClustalW alignment
of primary amino acid sequences from (top to bottom): 3′-5′-cAMP phosphodiesterase from P. aeruginosa (CpdA Uniprot ID: D4P095); 3′-5′-cAMP
phosphodiesterase from Escherichia coli (CpdA Uniprot ID: E1PE04); 3′-5′-cAMP phosphodiesterase from Mycobacterium tuberculosis (lcc Uniprot
ID: 006629); and glycerophosphodiesterase from Enterobacter aerogenes (phosphohydrolase Uniprot ID: Q6XBH1). The alignment was manually
adjusted to fit minor mismatches. The boxed residues indicate identity (dark gray) or similarity (light gray). The five conserved, histidine-rich
regions that make up the metal ion-binding sites are numbered in roman numerals. The conserved L187 and R75 are arrowed. The final 32
residues for the M. tuberculosis phosphodiesterase (006629) are deleted as there is not an equivalent C-terminal sequence in the other three
proteins. (B) Homology model of CpdA from P. aeruginosa using the Rv0805 resolved structure (PDB: 3IB8) from M. tuberculosis as the template.
The homodimer is shown with one protomer colored and the other in grayscale. Helices are in red, strands in yellow, and loops in green. 5′-
cAMP was cocrystallized in the active site and is shown as space-filled blue spheres. The a-strands 4, 5, and 6 are indicated, as are the L187 and
R75 residues. (C) Pseudomonas aeruginosa CpdA homology model showing the amino acid substitution L187R. Model depicts a close-up section
of the CpdA dimer with one protomer in color and the other in grayscale. Left panel shows the conserved L187 residue and relevant secondary
structural elements indicated by arrows and right panel shows the substituted R187 residue and relevant secondary structural elements indicated
by arrows. (D) Model depicts a close-up section of one of the CpdA protomers. The residues D28, R31, R75, and their positively charged side
chains are indicated, as are relevant secondary structural elements.
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substituted with arginine or glycine in PAO1fimLRev1 and
PAO1fimLRev2, respectively. From this alignment, it is
clear that leucine187 and arginine75 are highly conserved
in all of these CpdA homologs, suggesting that substitu-
tions at these positions may affect the ability of the
enzyme to utilize cAMP as a substrate.
The CpdA homolog in M. tuberculosis is the cyclic
nucleotide phosphodiesterase Rv0805, and in E. aerogenes
is the glycerophosphodiesterase GpdQ. Crystal structures
of both Rv0805 and GpdQ have been solved (Jackson
et al. 2007; Shenoy et al. 2007; Podobnik et al. 2009).
Although the E. aerogenes esterase does not hydrolyze
cAMP, it does belong to the same metallo-phosphoester-
ase family of enzymes that hydrolyses the 3′-5′ phospho-
diester bond of glycerophosphodiesters (Jackson et al.
2007). Thus, GpdQ contains the same a/b barrel metallo-
phosphoesterase fold as Rv0805 from M. tuberculosis.
Despite their different substrate specificities, the core and
homodimer interfacial regions of GpdQ and Rv0805 are
strikingly similar, with only a 2.1 A r.m.s deviation between
the dimers of the two structures (Podobnik et al. 2009).
A homology model of P. aeruginosa CpdA was gener-
ated using the comparative alignment of Rv0805 and
CpdA (Fig. 4A). The structure of M. tuberculosis Rv0805
(PDB: 3IB8) was then used as the template to build the
CpdA three-dimensional structure using Modeller (Sali
and Blundell 1993). The rendered homology model of the
complete homodimer of wild-type CpdA from P. aerugin-
osa is depicted in Figure 4B.
We then explored the predicted effects of the cpdA
SNPs present in PAO1fimLRev1 (L187R) and PAO1fimLRev2
(R75G). The highly conserved L187 occurs at the C-
terminus of a-helix 6, and is buried in the hydrophobic
core of the protein (Fig. 4C). The L187R amino acid
substitution, in placing the large and hydrophilic arginine
side chain in this buried location, would likely destabilize
the structural integrity of the surrounding region. This
includes secondary structural elements, a5, a6, b8, and
b9, which provide anchor points for loops involved in
formation of the substrate-binding pocket (Fig. 4B and
C). Thus, while L187 is somewhat remote from the active
site, its mutation could affect function via its influence
on the structure and/or dynamics of these important sec-
ondary structural elements. In addition, the hydrophobic
pocket in which L187 resides also includes b-strand 9 and
the loop joining it to b-strand 8, which form a significant
part of the dimer interface, interacting with b-strand 11’
from the opposite protomer in the homodimer (Fig. 4C).
Thus, the L187R substitution could also influence enzyme
function by affecting the dimer interface, the dimer being
the active form of the enzyme.
R75 occurs in a-helix 2 (Fig. 4B) and may be involved
in stabilizing the loop at the N-terminus of a-helix 1
through a salt bridge to D28 and a hydrogen bond to the
backbone carbonyl oxygen of E27 (Fig. 4D). This loop
contains R31, which is in close proximity to the phos-
phate group of the bound cAMP, and therefore may be
involved in catalysis (Fig. 4D). The R75G substitution
could therefore destabilize the geometry of the active site
and effect substrate binding and/or catalysis at the active
site.
Extragenic suppressor mutations of fimL are
not in cyaA, cyaB, vfr, pilG, or pilH
Our analyses have revealed that PAO1fimLRev1 and PAO1-
fimLRev2 have acquired SNPs in cpdA that lead to
either loss of function in the CpdAL187R allele from
PAO1fimLRev1 or reduced activity in the CpdAR75G allele
from PAO1fimLRev2. The SNP present in PAO1fimLRev1
appears to fully account for the phenotypic reversion of
this strain as introduction of the wild-type CpdA allele
restores the parental fimL mutant twitching-motility and
icAMP phenotypes. Interestingly, the parental fimL
phenotypes were not restored to any of the remaining
revertants, including PAO1fimLRev2, by introduction of
pUCPCpdA, indicating that at least one other site of
extragenic suppressor mutation exists in these strains. As
all revertants have elevated icAMP levels, the site(s) of ex-
tragenic suppressor mutation in these strains likely occurs
in a gene encoding a factor involved in controlling intra-
cellular cAMP levels. In an attempt to identify these alter-
nate sites of extragenic suppressor mutation, we cloned
and sequenced the coding genes and upstream promoter
regions of cyaA, cyaB, vfr, pilG, and pilH from our PAO1
strain and fimL revertants PAO1fimLRev2, PAO1fimLRev3,
PAO1fimLRev4, and PAO1fimLRev5. No mutations were
identified in any of these regions compared with the
wild-type P. aeruginosa PAO1 reference sequence (Stover
et al. 2000; Winsor et al. 2011). Therefore, the sites of
extragenic suppressor mutation in these fimL revertants
must occur within other components that are involved in
modulation of icAMP levels.
Discussion
In this study, we have characterized five independent fimL
twitching-motility revertants and determined that each
revertant has increased icAMP levels compared with the
parental fimL mutant. Interestingly, the icAMP levels dif-
fered between the revertants, with three of the five dis-
playing extremely high levels of icAMP. Furthermore,
while macroscopic sub-surface stab assays demonstrated
that each revertant had restored twitching motility-
mediated interstitial biofilm expansion to almost wild-type
levels, microscopic examination revealed differences in the
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micromorphological patterning of the expanding biofilms.
Sequencing of the whole genome of PAO1fimLRev1, identi-
fied a number of SNPs, including one in cpdA which
encodes a cAMP phosphodiesterase. We demonstrated
that this SNP (CpdAL187R) results in a loss-of-function
mutation of CpdA, and is responsible for the observed
increase in icAMP levels and restoration of twitching
motility in PAO1fimLRev1. We also determined that a sec-
ond revertant, PAO1fimLRev2, possesses a different SNP in
cpdA (CpdAR75G), which likely results in reduced activity
of CpdA. However, it is not clear whether this SNP
accounts for the increased icAMP levels and restoration
of twitching motility in PAO1fimLRev2 as introduction of
wild-type CpdA to this revertant did not restore the
parental fimL mutant phenotypes. These observations sug-
gested that either the SNP in cpdA is not the primary site
of mutation responsible for the phenotypic reversion or,
alternatively, that the CpdAR75G allele has a dominant
negative influence over the introduced wild-type CpdA
allele. However, we found that when the CpdAR75G allele
was introduced into a wild-type cpdA background, the
levels of icAMP were reduced rather than elevated. This
indicates that the CpdAR75G allele possesses some cAMP
phosphodiesterase activity and that this allele is not domi-
nant negative over the wild-type allele. It is probable,
therefore, that the primary site of suppressor mutation
occurs elsewhere in the genome of PAO1fimLRev2.
Interestingly, the three remaining revertants (PAO1-
fimLRev3, PAO1fimLRev4, and PAO1fimLRev5) were found
to have wild-type cpdA sequences indicating that the sup-
pressor mutation has occurred elsewhere in the genomes
of these strains. The observed differences in the twitch-
ing-motility and icAMP phenotypes of the five revertants
are also consistent with the possibility that there are at
least two mechanisms of reversion. PAO1fimLRev1, PAO1-
fimLRev3, PAO1fimLRev5 each have very high levels of
icAMP and near-wild-type twitching motility when exam-
ined microscopically, yet only PAO1fimLRev1 has acquired
a SNP in cpdA. Furthermore, PAO1fimLRev2 has twofold
higher icAMP levels relative to PAO1 and slightly
aberrant twitching motility, whereas PAO1fimLRev4 has
wild-type icAMP levels but very aberrant twitching
motility when examined microscopically.
Sequencing did not reveal any mutations in the coding
and upstream promoter regions of cyaA, cyaB, vfr, pilG,
and pilH in the fimL revertants, indicating that the site(s)
of extragenic suppressor mutation must occur within
another gene encoding a factor that is involved in control
of icAMP levels in P. aeruginosa. The Chp chemosensory
system, which has been shown to be involved in control-
ling icAMP levels and twitching motility (Darzins 1993,
1994, 1995; Whitchurch et al. 2004; Fulcher et al. 2010),
encompasses an approximately 15 kb region. It is possible
that the alternate site(s) of extragenic suppressor muta-
tion is present within this region; however, it is also pos-
sible that there are additional components involved in
controlling icAMP that are yet to be identified.
In this study, we have investigated the mechanism of
twitching-motility reversion in five independent P. aeru-
ginosa fimL mutants. This revealed that increasing intra-
cellular cAMP levels is a general mechanism of twitching-
motility reversion in fimL mutants and that this increase
can occur via at least two different mechanisms. cAMP is
an important second-messenger signal associated with
virulence factor regulation in P. aeruginosa. Allosteric reg-
ulation by cAMP of the transcriptional activator Vfr
(West et al. 1994) controls the expression of a large range
of virulence-associated genes (Albus et al. 1997; Beatson
et al. 2002; Dasgupta et al. 2002; Wolfgang et al. 2003),
and it is therefore imperative that icAMP homeostasis is
tightly controlled. Regulation of the adenylate cyclases,
CyaA and CyaB, and the phosphodiesterase CpdA, which
synthesize and breakdown cAMP, respectively, (Wolfgang
et al. 2003; Fuchs et al. 2010; Fulcher et al. 2010) is medi-
ated by a number of complex, intersecting pathways
(Fulcher et al. 2010; Inclan et al. 2011), which is still not
fully understood. Identification of the sites of extragenic
suppressor mutation in the fimL mutant revertants that
do not contain SNPs in cpdA will further increase our
understanding of how icAMP levels and twitching motil-
ity are regulated to ultimately contribute to the overall
virulence of P. aeruginosa.
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